stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Total debt
AtriCure, Inc.'s total debt at the end of fiscal 2025 was $61.9M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $61.0M. Over the past ten years it has ranged from $13.7M (fiscal 2015) to $73.6M (fiscal 2019); the current reading is higher than 64% of that period. AtriCure, Inc. ranks 26th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $61.9M | 0.00% |
| FY2024 | $61.9M | 2.10% |
| FY2023 | $60.6M | (15.20%) |
| FY2022 | $71.5M | (0.18%) |
| FY2021 | $71.6M | 8.20% |
| FY2020 | $66.2M | (10.15%) |
| FY2019 | $73.6M | 40.35% |
| FY2018 | $52.5M | 40.18% |
| FY2017 | $37.4M | (3.78%) |
| FY2016 | $38.9M | 183.68% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $61.0M | (14.14%) |
| Jun 2026 | $71.0M | (1.03%) |
| Mar 2026 | $71.8M | (2.18%) |
| Dec 2025 | $73.4M | (0.48%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| XRAY DENTSPLY SIRONA Inc. compare | $2.0B |
| NVST Envista Holdings Corporation compare | $1.4B |
| ICUI ICU Medical, Inc. compare | $1.2B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| STVN Stevanato Group S.p.A. compare | $545.0M |
| WRBY Warby Parker Inc. compare | $170.2M |
| ATRC AtriCure, Inc. | $61.0M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement